Improved engraftment and therapeutic efficacy by human genome-edited hematopoietic stem cells with Busulfan-based myeloablation is a research paper published in Molecular Therapy — Methods & Clinical Development (2022). On theSindex it has a DataRank of 0. It has been cited 18 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NINDS NIH HHS
Grant: K08 NS102398
National Institutes of Health
Grant: 5K08NS102398-02
Correction of Mucopolysaccharidosis type 1: Targeting safe harbor loci using genome editing
NIH
University of Pennsylvania The Orphan Disease Center
FWCI
2.86
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals